Atossa Therapeutics, Inc. to Attend the 24th Annual H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Atossa Therapeutics, Inc. (Nasdaq: ATOS) is set to participate in the 24th Annual H.C. Wainwright Global Investment Conference from September 12-14, 2022, at the Lotte New York Palace. Kyle Guse, General Counsel and CFO, will represent the company and is available for one-on-one meetings.

Atossa focuses on developing innovative therapies for unmet medical needs in oncology and infectious diseases, particularly in breast cancer and COVID-19.

For meeting requests and conference registration, visit here.

SEATTLE, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious disease with a current focus on breast cancer and COVID-19, announced today that Kyle Guse, General Counsel & Chief Financial Officer will attend the 24^th Annual H.C. Wainwright Global Investment Conference being held on September 12 – 14, 2022 at the Lotte New York Palace.

Mr. Guse will be available for one-on-one meetings. To request a meeting and to register for the conference, click below:

https://hcwevents.com/annualconference/

About Atossa Therapeutics

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast cancer and COVID-19.

For more information, please visit www.atossatherapeutics.com

Contact:

Atossa Therapeutics, Inc.
Kyle Guse, General Counsel and Chief Financial Officer
kyle.guse@atossainc.com

FAQ

What is the date of the 24th Annual H.C. Wainwright Global Investment Conference for Atossa Therapeutics?

The conference will take place from September 12 to 14, 2022.

Who will represent Atossa Therapeutics at the investment conference?

Kyle Guse, General Counsel and CFO, will represent Atossa Therapeutics.

What is the primary focus of Atossa Therapeutics?

Atossa Therapeutics focuses on developing treatments for breast cancer and infectious diseases, including COVID-19.

How can I request a meeting with Atossa Therapeutics during the conference?

You can request a meeting and register for the conference by visiting the H.C. Wainwright event page.

Where will the conference be held?

The 24th Annual H.C. Wainwright Global Investment Conference will be held at the Lotte New York Palace.